Replies to post #860 on VistaGen Therapeutics Inc (VTGN)

[Hedge Starz]

Fact Sheet (and more) for $VSTA - http://vistagen.com/fact_sheet/index.html
Letter to Shareholders - http://www.vistagen.com/CEO_Update_Letter_to_Shareholders.pdf
CEO Interview - http://www.vsta.missionir.com/vsta-12-11.mp3

PARTNERSHIPS -
*University Health Network (UHN)
We extended through September 2017 and expanded the scope of our primary stem cell research and development
collaboration with Dr. Gordon Keller, one of the world’s leading stem cell researchers, and UHN, one of Canada s
largest research hospitals.
•Synterys
We signed a medicinal chemistry collaboration agreement with Synterys to support our future drug rescue programs.
•Cato Research and Cato BioVentures
We expanded our 10-year relationship with Cato Research and Cato BioVentures with a right of first offer agreement
focused on increasing our access to large market drug rescue opportunities.
•Duke University
We entered into a drug rescue research collaboration with Duke University aimed at integrating Duke s complementary
expertise at the forefront of cardiac stem cell technology, electrophysiology and tissue engineering.
•Vala Sciences
We entered into a drug screening collaboration with Vala Sciences to advance current methodologies used to screen
new drug candidates by